ANDREA CRUZ to Cost-Benefit Analysis
This is a "connection" page, showing publications ANDREA CRUZ has written about Cost-Benefit Analysis.
Connection Strength
0.091
-
Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children. Int J Tuberc Lung Dis. 2014 Sep; 18(9):1057-61.
Score: 0.091
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.